Green Cures Debt

GRCU Stock  USD 0.0001  0.0001  50.00%   
Green Cures Botanical holds a debt-to-equity ratio of 0.091. . Green Cures' financial risk is the risk to Green Cures stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Green Cures' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Green Cures' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Green Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Green Cures' stakeholders.
For most companies, including Green Cures, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Green Cures Botanical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Green Cures' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Green Cures' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Green Cures is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Green Cures to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Green Cures is said to be less leveraged. If creditors hold a majority of Green Cures' assets, the Company is said to be highly leveraged.
  
Check out the analysis of Green Cures Fundamentals Over Time.

Green Cures Botanical Debt to Cash Allocation

Green Cures Botanical currently holds 3.1 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Green Cures Botanical has a current ratio of 4.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Green Cures until it has trouble settling it off, either with new capital or with free cash flow. So, Green Cures' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Green Cures Botanical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Green to invest in growth at high rates of return. When we think about Green Cures' use of debt, we should always consider it together with cash and equity.

Green Cures Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Green Cures' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Green Cures, which in turn will lower the firm's financial flexibility.

Green Cures Corporate Bonds Issued

Understaning Green Cures Use of Financial Leverage

Green Cures' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Green Cures' current equity. If creditors own a majority of Green Cures' assets, the company is considered highly leveraged. Understanding the composition and structure of Green Cures' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people.
Please read more on our technical analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Green Pink Sheet Analysis

When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.